Skip to Main Content

Paper Details

CDC25 as a common therapeutic target for triple-negative breast cancer - the challenges ahead.
Mol Cell Oncol
7
2018
CDC25, P53, PI3K, PTEN, RB1, RB1/PTEN/P53-deficient tumors, triple-negative breast cancer, triple-negative breast cancers, tumor
Author NameAffiliation
Eldad ZacksenhausToronto General Research Institute - University Health Network
Eldad ZacksenhausUniversity of Toronto
Eldad ZacksenhausUniversity of Toronto
Dong-Yu WangToronto General Research Institute - University Health Network
Amjad AliToronto General Research Institute - University Health Network
Amjad AliToronto General Research Institute - University Health Network
Zhe JiangToronto General Research Institute - University Health Network
  • 1 - 7

Datasets

Release 1.2